Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), andMDS/MPNdiseases. Differences betweenMDSandMDS/MPN

Keyphrases

• Bone Marrow Aspirate 16%
• Cell Lineage 16%
• Diagnostic Histopathology 16%
• Diagnostic Purposes 16%
• Distinct Patterns 16%
• Early Maturation 16%
• Flow Cytometric Analysis 16%
• Flow Cytometry 16%
• Hematologic Neoplasms 16%
• Hematopoietic Cell Lineage 16%
• Hematopoietic Cells 16%
• Ki-67 16%
• Ki-67 Expression 50%
• Malignancy 33%
• Maturation Stage 33%
• Monopoiesis 16%
• Myelodysplastic Syndrome 100%
• Myelodysplastic Syndrome/myeloproliferative Neoplasm 83%
• Myeloproliferative Neoplasms 100%
• Nonmalignant 16%
• Pathobiology 16%
• Patient Cohort 33%
• Prognostic Marker 16%
• Proliferation Marker Ki-67 16%
• Proliferative Activity 100%
• Solid Cancer 16%

Immunology and Microbiology

• Cell Lineage 50%
• Hematopoietic Cell 50%
• Maturation 100%

Biochemistry, Genetics and Molecular Biology

• Hematopoietic Cell 50%